FDA clears Philips’ SmartSpeed Precise

Philips has secured U.S. Food and Drug Administration (FDA) clearance for its SmartSpeed Precise MRI deep-learning reconstruction software. 

The software was unveiled at ECR 2025 and is now cleared for clinical use in the U.S. SmartSpeed Precise features integrated dual AI engines, a denoising engine, and a second engine for image sharpening and anti-ringing. The technology enables significantly faster scans and up to 80% sharper images with a single click, the company said. The technology is available across Philips' entire portfolio of 1.5-tesla and 3-tesla MRI systems, it noted.